Page 50 - GPD-1-2
P. 50

Gene & Protein in Disease                                                         circRNAs and cancer



            promotion  of nuclear translocation  of these proteins .   2.3. GC
                                                        [38]
            Similarly, FECR1, a novel circular RNA generated from the   GC is a major source of mortality and a significant financial
            FLI1 gene, regulates DNA methylation/demethylation of   burden on health-care systems worldwide . CircRNAs are
                                                                                                [48]
            target genes to mediate BC cell metastasis [7,39] . In addition,   reported to be stable in plasma and gastric juice, making
            the increase expression of circAGFG1 in TNBC increases   them an ideal diagnostic marker for GC. Three circRNAs
            cell proliferation, migration, invasion, tumor development,   (has_circ_002059, hsa_circ_0000190, and circ-0001649)
            and metastasis by serving as ceRNA for  miR-195-5p to   are variably expressed in the plasma of post-operative GC
            diminish its target genes’ inhibitory function [40,41] .  patients compared to pre-operative GC individuals. They
              On the contrary,  circFOXO3 is significantly lowered   are considerably downregulated in GC tissues compared
                                                                                                           [49]
            in BC tissues compared to the adjacent normal ones .   to nearby tissues with average physiological properties .
                                                        [36]
            Abnormal  circ-FOXO3 triggers programmed death and   The reduced expression of the above three circRNAs
            prevents tumor cell development. On the other hand,   correlates significantly with gender, age, distal metastasis,
            overexpression  of  circFOXO3  leads  to  the  increase  of   and TNM stage [50-52] . However, circHIPK3, but not HIPK3
            its parental gene expression and upregulates the genes   mRNA, is upregulated in GC and significantly affects
            responsible for cell deaths. For example, PUMA inhibits   cell  proliferation.  CircHIPK3  expression  is  substantially
            p53 expression and promotes  MDM2-induced p53      higher than HIPK3 mRNA, thus it demonstrates its crucial
                                                                                                 [19]
            degradation. In addition,  circ-CCNB1 is significantly   role as a product of pre-HIPK3 mRNA .  CircPVT1,
            suppressed in BC. It has been demonstrated that  circ-  overexpressed in GC, has been identified to promote cell
            CCNB1  in p53 mutant cells forms a  compound with   proliferation. Mortality risk and time without developing
            H2AX and BCLAF1 mediating apoptosis . In TNBC, the   an illness positively correlate with its interaction with miR-
                                            [39]
                                                                              [27]
            downregulation of circTADA2A-E6 inhibits proliferation,   125 in GC patients . CircPVT1 mediates its function by
            motility, and infiltration. circTADA2A-E6 serves as a miR-  upregulating c-Myc oncoprotein levels in GC cells and acts
            203a-3p sponge and restores the production of miRNA   as a sponge for let-7b. CircRNAs are expressed differently,
            targeting the  SOCS3 gene, leading to the less invasive   they interact with miRNAs through their binding sites to
            neoplastic phenotype. It concludes that circRNAs can   control the transcription of their downstream targets and
                                                               may serve as a novel biomarker for GC .
                                                                                              [53]
            mediate BC by acting as oncogenes or suppressors.
                                                               2.4. CRC
            2.2. OC
                                                               A study showed a negative correlation between the total
            OC is a highly aggressive tumor among gynecological   circRNAs abundance and cell proliferation in CRC, where
            malignancies and is primarily diagnosed in advance .   its  high  expression  suppressed  cell  proliferation .  The
                                                        [42]
                                                                                                       [32]
            Multiple cancer-related signaling pathways, usually   circ-ITCH was significantly lowered in CRC tissues.
            activated  by  linear  mRNA,  can  be  downregulated  by   Its  deficiency  upregulated  ITCH  expression,  which
            circRNAs, indicating a potential role of circRNAs in tumor   blocked the Wnt/beta-catenin  pathway . However,
                                                                                                  [54]
            activation or inhibition . CircRNAs exhibit differential   circ_0060745  was  upregulated  in  CRC  and  linked
                               [43]
            expression among  OC  patients and  healthy  individuals,   with cellular propagation and metastasis through the
            showing their potential roles as both the therapeutic   sequestering of miR-4736 and elevation of CSE1L levels .
                                                                                                           [55]
            and diagnostic biomarkers for this disease . Ning et al.   Similarly, an analysis of 50 CRC tissue samples revealed
                                              [44]
            investigated circRNAs expression in EOC tissue samples   that hsa_circ_0007142 is upregulated and linked with
            and identified that 2556 circRNAs are upregulated,   poor differentiation, and metastasis to the lymph nodes is
            and 1832 circRNAs are downregulated compared with   mediated by its binding to miR-103a-2-5p . Furthermore,
                                                                                                [56]
            normal ovarian tissue samples . Moreover, among the   circ-BANP is overexpressed in CRC tissues, and its
                                     [45]
            dysregulated circRNAs,  circEXOC6B and  circN4BP2L2   silencing suppresses cellular multiplication . Other
                                                                                                     [57]
            were suggested to possess a potential prognostic disease-  circRNAs reported to be upregulated in CRC include ciRS-
            specific biomarker. Similarly, hsa_circ_0061140 has also   7 ,  circCCDC66 , and has_circ_0000069 . They are
                                                                             [28]
                                                                                                   [59]
                                                                [58]
            been elevated in OC cells, which directly controls FOXM1   also associated with clinicopathological variables such as
            expression by binding to miR-370, thus  promoting cell   age and TNM stage. According to Zhang et al.’s research of
            proliferation, migration, and epithelial-mesenchymal   the human circRNAs array in CRC tissues, hsa circRNAs
            transition  (EMT) .  However,  CircHIPK3  (hsa_    103809 and 104700 were dramatically downregulated
                            [46]
            circ_0000284) is substantially related to multiplication,   and associated with lymph nodes, tumors, and distant
            motility,  invasive,  and  apoptosis  inhibition  through   metastasis .  CircRNAs are expressed differently  to
                                                                       [60]
            binding to miR-10-5p .                             mediate cancer development.
                             [47]
            Volume 1 Issue 2 (2022)                         3                      https://doi.org/10.36922/gpd.v1i2.138
   45   46   47   48   49   50   51   52   53   54   55